Literature DB >> 25386291

Cutaneous plasmacytosis: a case report and review of pulmonary findings.

Weeranut Chantachaeng1, Leena Chularojanamontri1.   

Abstract

Primary cutaneous plasmacytosis is an uncommon cutaneous disorder with multiple cutaneous nodules and plaques mainly on face and trunk. This entity is thought to be a reactive process with unknown etiology. Pulmonary involvement could be found as a part of systemic plasmacytosis whereas cutaneous plasmacytosis was also reported with other pulmonary disorders. This report presents the case of cutaneous plasmacytosis and the review of pulmonary findings reported in plasmacytosis.

Entities:  

Keywords:  plasmacytosis; pulmonary findings.

Year:  2011        PMID: 25386291      PMCID: PMC4211499          DOI: 10.4081/dr.2011.e39

Source DB:  PubMed          Journal:  Dermatol Reports        ISSN: 2036-7392


Introduction

The primary cutaneous plasma cell disorders can range from malignant to benign plasma cell neoplasms. The malignant conditions are neoplastic diseases having monoclonal proliferations, rapid progression and fatal outcome while the benign plasma cell disorders usually show polyclonality, chronicity and benign process, including plasmacytosis.[1] Some authors stated that cutaneous and systemic plasmacytosis should be the same entity because systemic involvement has not been found in the former due to a lack of sufficient investigations.[2] In this report, the authors present a case of cutaneous plasmacytosis, which is a rare reactive skin condition and also a review pulmonary findings in this disease.

Case Report

A 41-year-old male presented with the history of persistent asymptomatic papules and plaques on face, neck and trunk which gradually increased over two years (Figure 1). Physical examination revealed multiple discrete infiltrative erythematous to brownish plaques and nodules on face, neck, trunk and back. The skin biopsy showed superficial and deep perivascular and periadnexal infiltrations with mature plasma cells, admixed with some lymphocytes and histiocytes with no atypicality (Figure 2). The immunohistochemistry revealed no light chain restriction.
Figure 1

Multiple discrete infiltrative erythematous to brownish papules and plaques on chest wall and trunk.

Figure 2

Perivascular and periadnexal infiltrations predominately with mature plasma cells, admixed with lymphocytes and histiocytes. No atypical plasma cells were observed.

Multiple discrete infiltrative erythematous to brownish papules and plaques on chest wall and trunk. Perivascular and periadnexal infiltrations predominately with mature plasma cells, admixed with lymphocytes and histiocytes. No atypical plasma cells were observed. Basic chemical laboratory testing was within normal limits. Serology for anti-human immunodeficiency virus, anti-nuclear antibody and syphilis were negative. Urine Bence Jones protein, β2-microglobulin, serum free light chain analysis and serum protein electrophoresis were all within normal limits. Bone marrow biopsy resulted in moderately hypercellularity with normal maturation. However, a speculated lung nodule with cavity 1.7 cm in diameter was seen at right upper lobe from chest X-ray. Three consecutive sputum examinations were negative for acid fast bacilli. With previous reports of pulmonary involvement in plasmacytosis, computer tomography (CT) scan of the chest was done and revealed a group of cavitary pulmonary nodules with nearby tree-in-bud pattern, suggestive of tuberculosis rather than malignancy. Finally, the diagnosis of pulmonary tuberculosis was confirmed by bronchoalveolar fluid culture and lung biopsy. After successful course of 6-month anti-tuberculosis regimen, there was a resolution of pulmonary lesions but skin lesions still progressed gradually. Intralesional steroid injection and tacrolimus ointment application were commenced but did not show promising results. Then, the patient decided to have a scheduled follow-up visits. Primary cutaneous plasmacytosis or cutaneous plasmacytosis was thought to be a reactive process with unknown etiology and characterized by disseminated, asymptomatic reddish-brown macules, plaques and nodules mainly on upper trunk and face. Classification for cutaneous plasmacytosis was coined by Watanabe et al. in 1986.[1] Cutaneous plasmacytosis without pulmonary involvement by definition, had been reported with some abnormal pulmonary findings such as lung carcinoma and lung nodules.[2,3]A primary plasmacytosis affecting more than two organs was classified as systemic plasmacytosis. The common organ involvements were superficial lymphadenopathy (58%) and hepatosplenomegaly (28%), respectively.[4] Pulmonary findings of systemic and cutanoeus plasmacytosis were demonstrated as Table 1. As far as the author's review, there were two cases which had pulmonary granuloma and plasmacytosis (case No. 4, 5).
Table 1

Clinical features of systemic and cutaneous plasmacytosis patients with abnormal pulmonary findings.

PatientAge / SexLocation of lesionsSymptomsRadiographic and pathologic findings of lungDiagnosisTreatments and outcome
1.49/F Korean[5]Face, chest and backFatique, shortness of breath and dry coughCT: innumerable tiny perivascular nodules Biopsy: mature plasma cells infiltrationsSystemic plasmacytosis (cutaeous, lymphadenopathy and lungs)

CHOP regimen: partial response

Anti CD-20: no response

Prednisolone (1 mg/Kg/D): reduction in pulmonary symptoms and lymphadenopathy but no improvement of cutaneous lesions

2.62/F Japanese[1]Chest and backDyspnea on exertion, wheezing and coughCXR: reticulonodular both lower lungs Biopsy: follicle formations with infiltration of plasma cells and lymphocytes, alveolar wall fibrosis foundSystemic plasmacytosis (cutaneous, lymphadenopathy and lungs)Died due to respiratory failure despite prednisolone therapy and various kinds of treatments
3.54/M Japanese[6]Chest and abdomenFatigueCT: ground-glass attenuation with reticular infiltration in middle and lower lobes Biopsy: thickening of alveolar septum with marked infiltration of lymphoplasmacytic cellsSystemic plasmacytosis (cutaneous, lymphadenopathy and lung)Prednisolone (15mg/D): partial response
4.67/M Chinese[7]Trunk and extremitiesAsymptomatic, history of treated pulmonary tuberculosisCT: a foci of ground-glass attenuation with calcified granuloma, multiple axillary and intrathoracic lymphadenopathy Biopsy: not doneSystemic plasmacytosis (cutaneous, lymphadenopathy and lung)N/A
5.35/F Philippino[3]Forehead axillae inframammaryFatigueCT: 2 small pulmonary nodules Biopsy: not done (thought to represent granuloma)Cutaneous plasmacytosis with pulmonary nodules3 years follow-up without any treatment: stable and aymptomatic
6.55/M Caucasian[2]Back and trunkFever, malaise and significant weight loss. History of anal chronic ulcerCT: pulmonary mass of left lingular lobe with multiple lymph nodes Biopsy: squamous cell carcinomaCutaneous plasmacytosi with lung and anal carcinomasDied from respiratory and circulatory failure
7. present case35/M ThaiFace, chest and upper backAsymptomaticCT: cavitary pulmonary nodules and centrilobular nodules at RUL Biopsy: necrotizing granulomatous inflammationCutaneous plasmacytosis with pulmonary tuberculosisResolved pulmonary lesions after anti-tuberculosis therapy but persistent cutaneous lesions despite of intralesional steroid and topical tacrolimus

CT, computer tomography; CXR, chest X rays; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisolone.

CHOP regimen: partial response Anti CD-20: no response Prednisolone (1 mg/Kg/D): reduction in pulmonary symptoms and lymphadenopathy but no improvement of cutaneous lesions CT, computer tomography; CXR, chest X rays; CHOP, cyclophosphamide, doxorubicin, vincristine, prednisolone. Uhara et al. reviewed that the most characteristic histopathologic change of plasmacytosis was perivascular and periadnexal patchy infiltration of matured typical plasma cells with some lymphocytes and histiocytes. Immunohistochemistry was found to be polyclonal IgG-positive predominated.[4] Other important differential diagnosis includes syphilis, Lyme disease, systemic lupus erythematosus and plasmacytoma.[8] The extensive investigations of our patient showed no distinctive causes of plasma cell proliferation. Firstly, the authors believed that cutaneous plasmacytosis might be a reactive process of pulmonary tuberculosis. However, the skin lesions did not resolve after successful course of anti-tuberculosis drugs. As a result, pulmonary tuberculosis, which occurs comonly in Thailand, was believed to be a coincidence rather than association with plasmacytosis. In vitro study had shown that three patients with cutaneous plasmacytosis had elevated plasma IL-6 levels which induced the final maturation of B cells into immunoglobulin-producing cells. IL-6 levels were subsequently decreased after steroid addition.[9] Tacrolimus application was reported to reduce erythema and induration.[10] Unfortunately, the patient did not show favorable outcome after three months of steroid injections and tacrolimus ointment, respectively.

Conclusions

In summary, the authors describe the rare case of cutaneous plasmacytosis which is diagnosed at the same time of pulmonary tuberculosis. Data from more patients are required in order to conclude that plasmacytosis is a reactive process or co-incidence of tuberculosis. However, lung is another organ that should be taken into consideration for sufficient investigation of plasmacytosis.
  10 in total

1.  Cutaneous plasmacytosis: A report of five cases with immunohistochemical evaluation for HHV-8 expression.

Authors:  Anu G Jayaraman; Christine Cesca; Sabine Kohler
Journal:  Am J Dermatopathol       Date:  2006-04       Impact factor: 1.533

2.  Cutaneous and systemic plasmacytosis.

Authors:  Aimee L Leonard; Shane A Meehan; David Ramsey; Lance Brown; Filiz Sen
Journal:  J Am Acad Dermatol       Date:  2006-09-14       Impact factor: 11.527

3.  Cutaneous plasmacytosis associated with lung and anal carcinomas.

Authors:  J M Martín; L Calduch; C Monteagudo; I Molina; D Ramón; V Alonso; E Jordá
Journal:  J Eur Acad Dermatol Venereol       Date:  2006-04       Impact factor: 6.166

Review 4.  Primary cutaneous plasmacytoma: report of a case with review of the literature.

Authors:  L M Muscardin; A Pulsoni; L Cerroni
Journal:  J Am Acad Dermatol       Date:  2000-11       Impact factor: 11.527

5.  Targeting T cells to hit B cells: successful treatment of cutaneous plasmacytosis with topical pimecrolimus.

Authors:  Christian Hafner; Ulrich Hohenleutner; Philipp Babilas; Michael Landthaler; Thomas Vogt
Journal:  Dermatology       Date:  2006       Impact factor: 5.366

6.  Intralesional steroid-therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis.

Authors:  T Yamamoto; K Soejima; I Katayama; K Nishioka
Journal:  Dermatology       Date:  1995       Impact factor: 5.366

7.  Cutaneous and systemic plasmacytosis in a patient of Asian descent living in the United States.

Authors:  Hesham M Amin; Peter McLaughlin; Cynthia J Rutherford; Lynne V Abruzzo; Dan Jones
Journal:  Am J Dermatopathol       Date:  2002-06       Impact factor: 1.533

8.  High ratio of IgG4-positive plasma cell infiltration in cutaneous plasmacytosis--is this a cutaneous manifestation of IgG4-related disease?

Authors:  Aya Miyagawa-Hayashino; Yumi Matsumura; Fumi Kawakami; Hideo Asada; Miki Tanioka; Akihiko Yoshizawa; Yoshiki Mikami; Hirokazu Kotani; Yasuaki Nakashima; Yoshiki Miyachi; Toshiaki Manabe
Journal:  Hum Pathol       Date:  2009-04-22       Impact factor: 3.466

Review 9.  Primary cutaneous plasmacytosis: report of three cases and review of the literature.

Authors:  H Uhara; T Saida; S Ikegawa; Y Yamazaki; H Mikoshiba; S Nijoh; K Kitano; C S Koh
Journal:  Dermatology       Date:  1994       Impact factor: 5.366

10.  Systemic plasmacytosis. A syndrome of peculiar multiple skin eruptions, generalized lymphadenopathy, and polyclonal hypergammaglobulinemia.

Authors:  S Watanabe; K Ohara; A Kukita; S Mori
Journal:  Arch Dermatol       Date:  1986-11
  10 in total
  1 in total

1.  Myalgia caused by chronic myositis associated with plasmacytosis: a case report.

Authors:  Taku Hatano; Masashi Takanashi; Hitoshi Tsuchihashi; Shin-Ichi Ueno; Arisa Hayashida; Yutaka Tsukune; Kazuaki Kanai; Yasushi Shimo; Nobutaka Hattori
Journal:  BMC Neurol       Date:  2018-08-14       Impact factor: 2.474

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.